Status:
COMPLETED
Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Menopause
Hormone Replacement Therapy, Post-Menopausal
Eligibility:
FEMALE
Brief Summary
This study is conducted in Europe. The aim of this study is to verify the therapeutic effects of low-dose hormone replacement therapy (HRT) in female patients over adequately long time period in norma...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Post-menopausal
Exclusion
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
3760 Patients enrolled
Trial Details
Trial ID
NCT01487304
Start Date
April 1 2005
End Date
June 1 2006
Last Update
October 17 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Prague, Czechia